Key result
PTMC is linked to acutely improved peak atrial longitudinal strain in severe rheumatic mitral stenosis.
Why the study?
This study aimed to assess left atrial functions using peak atrial longitudinal strain in patients with severe rheumatic mitral stenosis in sinus rhythm who underwent successful percutaneous transvenous mitral commissurotomy.
Does successful percutaneous transvenous mitral commissurotomy improve left atrial function as measured by peak atrial longitudinal strain in patients with severe rheumatic mitral stenosis in sinus rhythm?
Observational (n=50)
No
Does successful percutaneous transvenous mitral commissurotomy improve left atrial function as measured by peak atrial longitudinal strain in patients with severe rheumatic mitral stenosis in sinus rhythm?
p-value: p=< .001
Successful percutaneous transvenous mitral commissurotomy acutely improves left atrial function as measured by peak atrial longitudinal strain in patients with severe rheumatic mitral stenosis.
AIMS: Chronic rheumatic heart disease (RHD) is prevalent in India. The mitral valve in isolation or combination with the aortic or tricuspid valve is involved in 31.6% and 52.8% of chronic RHD patients, respectively. The left atrium (LA) functions as a reservoir during the cardiac cycle. Therefore, the LA enlargement leads to longitudinal lengthening, measured as a positive strain, permitting the measurement of the longitudinal strain of LA. This study aimed to assess the LA functions using peak atrial longitudinal strain (PALS) in patients with severe rheumatic mitral stenoses (MS) in sinus rhythm who underwent successful percutaneous transvenous mitral commissurotomy (PTMC). MATERIAL AND METHODS: We recruited 56 patients with severe rheumatic MS for the study, of which 06 PTMC procedures were considered unsuccessful. So, 50 patients of chronic severe rheumatic MS in sinus rhythm undergoing PTMC were enrolled in a tertiary care centre of the Armed Forces from August 2017 to May 2019. Patients included in the study were not consecutive, and patients with atrial fibrillation (AF) were excluded. RESULTS: PALS improved post-PTMC (P < .001) in this study, effectively concluding that PALS is impaired in patients with severe symptomatic MS and is acutely enhanced after treatment. CONCLUSIONS: PALS is a good indicator of LA function and may predict the success of PTMC on the rheumatic mitral valve.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2023) conducted an observational in Severe rheumatic mitral stenoses (n=50). Percutaneous transvenous mitral commissurotomy (PTMC) vs. Pre-PTMC baseline was evaluated on Peak atrial longitudinal strain (PALS) (p=< .001). Percutaneous transvenous mitral commissurotomy acutely improved peak atrial longitudinal strain in patients with severe symptomatic rheumatic mitral stenosis (P < .001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: